Immunic Inc (FRA:10VA)
€ 1.075 -0.039 (-3.5%) Market Cap: 98.58 Mil Enterprise Value: 26.16 Mil PE Ratio: 0 PB Ratio: 1.70 GF Score: 41/100

Immunic Inc Corporate Call Transcript

Nov 17, 2022 / 04:00PM GMT
Release Date Price: €1.49 (+5.04%)
Jessica Breu
Immunic, Inc. - Head of IR & Communications

Good morning, everybody. I'm sorry. I would like to welcome you to a very exciting R&D webcast around Immunic's multiple sclerosis development program. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic. I will also be the moderator on today's webcast.

As always, in the beginning of our webcast, I will walk through some organizational items first. Please note that all participants will be in listen-only mode, and this event is being recorded. During and after today's presentation, there will be an opportunity to ask questions. If you join the webcast via the Zoom platform, there are 2 ways to submit questions. You can either submit your questions in writing via the Q&A tool of the Zoom portal, or if you would like to speak with us directly, please use the Raise Hand function in the Zoom portal to queue your question.

Before we begin, I also would like to remind you that this presentation may contain forward-looking statements. Such statements can be identified by words such as may, will,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot